• 20-HETE-TRPV1 Signaling Drives Allokinesis in Chronic Dermat

  2026-07-06

  This study uncovers a novel mechanism by which the lipid metabolite 20-HETE activates TRPV1 channels on MrgprA3+ sensory neurons, driving itch and pain sensations in chronic dermatitis. The findings highlight potential intervention points for modulating sensory signaling in chronic skin conditions.

• AMPK Regulates Mitophagy-Inflammation in Diabetic Periodonta

  2026-07-06

  This study reveals how AMPK orchestrates the balance between PINK1/Parkin-mediated mitophagy and NLRP3-driven inflammation in periodontal ligament fibroblasts under mechanical loading, particularly in diabetic conditions. The findings highlight AMPK activation as a promising strategy for mitigating inflammation and preserving tissue homeostasis in periodontal disease.

• Meropenem Trihydrate: Carbapenem Antibiotic Workflows & Tips

  2026-07-05

  Meropenem trihydrate empowers resistance and infection research with robust β-lactamase stability and broad activity spectrum. This guide explores optimized protocols, real-world troubleshooting, and translational applications for leveraging APExBIO’s Meropenem trihydrate in advanced microbiology and metabolomics-driven studies.

• Phosphoenolpyruvate Restricts cGAS-Driven Inflammation in Ag

  2026-07-04

  A recent study demonstrates that phosphoenolpyruvate (PEP), a glycolytic metabolite, acts as a natural inhibitor of the cGAS–STING inflammatory pathway, thereby promoting healthy aging. This work reveals a conserved adaptive mechanism in metabolism–inflammation crosstalk and suggests that targeting glycolytic intermediates could support the development of anti-inflammaging interventions.

• Dabigatran etexilate: Direct Thrombin Inhibitor in Research

  2026-07-03

  Dabigatran etexilate’s potency and predictable oral bioavailability make it a cornerstone for modern anticoagulant and coagulation cascade research. This guide details optimized workflows, troubleshooting strategies, and the translational impact of this direct thrombin inhibitor, with actionable protocol parameters and insights from the latest clinical and laboratory evidence.

• AMG 9810: TRPV1 Antagonist Workflows in Sensory Neuron Resea

  2026-07-03

  AMG 9810 stands out as a potent, selective TRPV1 antagonist, enabling robust and reproducible inhibition of capsaicin-induced calcium influx in sensory neuron assays. This guide details actionable workflows, troubleshooting insights, and advanced applications for maximizing research outcomes with APExBIO’s AMG 9810.

• Hexamethonium Bromide: Precision Tools for Neuronal Signalin

  2026-07-02

  Hexamethonium Bromide stands out as a selective antagonist of neuronal-type nicotinic AChR, empowering researchers to dissect autonomic nervous system mechanisms with exceptional specificity. This article unpacks advanced protocols, troubleshooting insights, and key findings from recent hypertension research, positioning Hexamethonium Bromide as an indispensable reagent for translational neuronal signaling studies.

• DiscoveryProbe™ Metabolism-related Compound Library: Mechani

  2026-07-02

  Explore the DiscoveryProbe Metabolism-related Compound Library and its role in advanced pathway modulation for metabolism research. This article uniquely ties mechanistic findings from recent clinical metabolomics to practical assay design, offering novel guidance for translational studies.

• AMG 9810: Potent TRPV1 Antagonist for Sensory Signal Researc

  2026-07-01

  AMG 9810 is a selective TRPV1 antagonist with nanomolar potency. It blocks capsaicin-induced calcium influx and CGRP release, making it a benchmark compound for sensory neuron signaling studies. Supplied by APExBIO, AMG 9810 is validated by strict quality controls and is widely used in pain mechanism research.

• Sulfisomidine in Enzyme Kinetics & Antibacterial Research

  2026-07-01

  Sulfisomidine (sulfamethin) uniquely bridges enzyme inhibition and antibacterial applications, empowering both microbial metabolism and hPON1 studies. This guide delivers actionable protocols, advanced troubleshooting, and a practical synthesis of clinical and in vitro evidence for translational researchers.

• THZ1 (SKU A8882): Precision CDK7 Inhibition for Reliable T-A

  2026-06-30

  This article provides a scenario-driven, evidence-based overview of using THZ1 (SKU A8882), a covalent CDK7 inhibitor, to overcome common challenges in cell viability, proliferation, and cytotoxicity assays—especially in T-cell acute lymphoblastic leukemia (T-ALL) research. It contrasts product selection, protocol optimization, and data interpretation, highlighting why APExBIO’s THZ1 is favored for reproducibility and sensitivity in advanced cancer biology workflows.

• AG-221 (Enasidenib) in AML: Workflows, Resistance & Optimiza

  2026-06-30

  AG-221 (Enasidenib) revolutionizes acute myeloid leukemia research by selectively inhibiting mutant IDH2, enabling precise 2-hydroxyglutarate reduction and controlled cell differentiation. This article guides translational scientists through robust experimental workflows, resistance-minimizing strategies, and actionable troubleshooting tips, anchored by recent insights into metabolic rewiring.

• Methyl-β-cyclodextrin: Protocol Parameters and Workflow Guid

  2026-06-29

  Methyl-β-cyclodextrin is designed for efficient extraction of cholesterol and related lipids from cellular membranes, enabling precise study of membrane dynamics, lipid raft disruption, and cholesterol-dependent signaling. It is not intended for diagnostic, clinical, or therapeutic applications, and should be reserved for controlled experimental research workflows that demand strict adherence to storage and handling protocols.

• Cytoskeleton-Dependent Mechanotransduction Drives Autophagy

  2026-06-29

  This study establishes that the cytoskeleton, particularly microfilaments, is essential for mechanical stress-induced autophagy in human cells. The findings clarify how physical force is transduced into autophagic signaling, with broad implications for research on mechanotransduction and cellular homeostasis.

• Sulfo-Cy3 Azide: High-Fidelity Bioconjugation Reagent for Cl

  2026-06-28

  Sulfo-Cy3 azide empowers advanced Click Chemistry fluorescent labeling with unmatched photostability and water solubility. Its optimized performance streamlines bioconjugation workflows, enhancing signal clarity and reproducibility in complex biological samples.

14744 records 1/983 page Next 12345 下5页 Last page